Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Lantern Pharma Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 34 | 39 | +5 |
| Shares | 1.11M | 1.29M | +177.6K (+16.0%) |
| Value | $9.75M | $6.01M | −$3.75M (−38.4%) |
New holders (11)
Institutions that held Lantern Pharma Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Davenport & Co LLC | 63,814 | $298.0K | 0.00% |
| Two Sigma Investments, LP | 34,779 | $162.4K | 0.00% |
| Meridian Wealth Management, LLC | 14,945 | $69.8K | 0.01% |
| Jump Financial, LLC | 12,900 | $60.2K | 0.00% |
| Westside Investment Management, Inc. | 11,500 | $53.7K | 0.01% |
| Millennium Management LLC | 10,135 | $47.3K | 0.00% |
| Fisher Asset Management, LLC | 10,000 | $46.7K | 0.00% |
| FMR LLC | 530 | $2.47K | 0.00% |
| Cypress Capital, LLC | 200 | $934 | 0.00% |
| Federated Hermes, Inc. | 74 | $346 | 0.00% |
| Bank of America Corp | 69 | $322 | 0.00% |
Sold out (6)
Institutions that held Lantern Pharma Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Pathway Financial Advisors LLC | 25,001 | $220.0K |
| Jane Street Group, LLC | 24,872 | $218.9K |
| Tucker Asset Management LLC | 11,500 | $101.2K |
| Advisor Group Holdings, Inc. | 410 | $3.61K |
| The PNC Financial Services Group, Inc. | 250 | $2.20K |
| Stone House Investment Management, LLC | 200 | $1.76K |